Information, News & Discussion about Infant Pediatric & Adolescent Neurology & Sleep Disorders. Science Diagnostics Symptoms Treatment. Topics include: Seizures Epilepsy Spasticity Developmental Disorders Cerebral Palsy Headaches Tics Concussion Brain Injury Neurobehavioral Disorders ADHD Autism Serving Texas Children's Neurology, Epilepsy, Developmental & Sleep Problems in The Houston Area and The San Antonio / Central & South Texas Areas
Tuesday, August 25, 2015
Babies use expectations about what they perceive to shape their brains
Wednesday, June 10, 2015
Study: Infant's brains develop faster than we thought
Sunday, November 30, 2014
Study: A mother's presence soothes infants' brains
A mother's "TLC" not only can help soothe pain in infants, but it may also impact early brain development by altering gene activity in a part of the brain involved in emotions, according to new study from NYU Langone Medical Center.
Sunday, June 22, 2014
Brain abnormalities seen in late pre-term infants
Babies born 32 to 36 weeks into gestation may have smaller brains and other brain abnormalities that could lead to long-term developmental problems, according to a new study published online in the journal Radiology.
Monday, March 04, 2013
Study: Ultrasound shows risk of autism at birth
Low-birth-weight babies with a particular brain abnormality are at greater risk for autism, according to a new study that could provide doctors a signpost for early detection of the still poorly understood disorder.
Sunday, March 03, 2013
Connections in the Developing Brains of 3rd Trimester Babies
Saturday, February 23, 2013
Infant brain's blood flow is regulated differently than an adult brain
A new study by Columbia Engineering researchers finds that the infant brain does not control its blood flow in the same way as the adult brain. The paper, which the scientists say could change the way researchers study brain development in infants and children, is published in the February 18 Early Online edition ofProceedings of the National Academy of Sciences (PNAS).
Thursday, November 29, 2012
Study: Early Autism Intervention Improves Brain Responses to Social Cues
Saturday, October 27, 2012
Study: Preemies from Low-Income Families at High Risk for Dangerous Brain Bleeds
While interesting, I never know how to apply this data in the office, the NICU or my cerebral palsy clinics.... JR
Babies born prematurely to low-income parents have a disproportionately high risk for developing dangerous brain bleeds that require multiple surgeries and extensive follow-up, according to a small Johns Hopkins Children's Center study.
Tuesday, July 24, 2012
Cause of Common Childhood Tumors Identified
"We tend to treat all medulloblastomas as one disease without taking into account how heterogeneous the tumors are at the molecular level," said Yoon-Jae Cho, MD, an assistant professor of neurology and neurological sciences at Stanford, a pediatric neurologist at Packard Children's and the senior author of the new research. "This paper represents a finer-grained view of the genetic landscape of these tumors and provides us with some leads on how to develop new therapies."
The research, which appeared online in Nature July 22, is part of a large, ongoing effort to characterize genetic errors in medulloblastoma. Two companion studies on which Cho is a co-author will be published simultaneously with his paper. The three papers came from a consortium that involves scientists at Stanford, Packard Children's, the Broad Institute, Children's Hospital Boston, the Dana-Farber Cancer Institute, the German Cancer Research Center, Brandeis University and the Hospital for Sick Children in Toronto.
Current treatment for medulloblastoma, which originates in the cerebellum and affects about 250 U.S. children each year, begins with surgery to remove as much of the tumor as possible. Patients then receive a combination of radiation and chemotherapy, but the treatments are not tailored to the tumor's genetic characteristics.
Cho's team extracted DNA from 92 medulloblastoma tumors and compared it with DNA from matched blood samples from the same patients, uncovering 12 significant "point mutations" -- single-letter errors in the genetic code -- that occurred frequently in the brain cancer. A handful of the mutations had been previously identified in smaller studies of medulloblastoma, but several mutations were novel in both medulloblastoma and in cancer.
Among the newly identified mutations was one in an RNA helicase gene, DDX3X, which Cho said is the second-most common mutation in medulloblastoma tumors. "Mutations in this gene have now also been identified in other tumor types, such as chronic lymphocytic leukemia, and head and neck tumors," he said.
However, the researchers found that it was rare for the same gene mutated in several different patients' tumors. More commonly, mutations involving a set of genes regulating a single biological pathway were found in the tumors -- a pattern that is emerging across cancer genome sequencing efforts.
Though no single tumor in the study carried all 12 mutations, the researchers were able to categorize the tumors according to which mutations they possessed. "We now understand that there are certain tumors with particular genetic signatures that are really resistant to standard treatments," Cho said. Children with medulloblastoma do not routinely have their tumors' genetic signatures characterized, but Cho believes that such characterization coupled with targeted therapies could greatly enhance tumor treatment.
About two-thirds of medulloblastoma patients now survive five years past diagnosis, but many survivors suffer lasting physical or intellectual side effects from their cancer treatments. Drugs tailored to a tumor's genetic profile have the potential to save more patients while reducing side effects, Cho said.
Several of the mutations discovered affect cellular signals that switch large groups of genes on and off. "The dysregulation of these 'epigenetic programs' is becoming a common theme not only in medulloblastoma but across cancer," Cho said. Such pathways may be good targets for cancer drugs; indeed, drugs targeting one such pathway (histone methyltransferases) are currently in pre-clinical development, while agents against another pathway (Hedgehog signaling pathway) are entering phase-2 clinical trials for medulloblastoma.
Cho is the co-chair of a committee within the Pediatric Brain Tumor Consortium that guides which drugs should be moved into clinical trials next. "Our plan is that within the next one to two years we will be able to offer kids a new set of compounds that have a clear biological rationale based on our genomic studies." Cho said. "We want to make sure we're being careful of what we move forward with, but at the same time, for some of these kids we don't have many, if any, effective and durable treatment options."
Read more here
Saturday, June 30, 2012
Brain Scan Can Detect Early Signs of Autism in Infants
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3.
Saturday, May 19, 2012
Just What's Inside Those Breasts?
May 16, 2012
When writer Florence Williams was nursing her
second child, she read a research study about
toxins found in human breast milk. She decided
to test her own breast milk and shipped a
sample to a lab in Germany. What came back surprised her.
Trace amounts of pesticides, dioxin and a jet
fuel ingredient — as well as high to average
levels of flame retardants — were all found in
her breast milk. How could something like this
happen?
"It turns out that our breasts are almost like
sponges, the way they can soak up some of these chemicals, especially the ones that are fat
loving — the ones [that] tend to accumulate in fat tissue," Williams tells Fresh Air's Terry Gross.
"Unfortunately, the breast is also masterful at converting these molecules into food in the way of
breast milk."
Learning that breasts soak up lots of chemicals made Williams wonder just what else was going on
with breasts. A lot, as it turns out. In her new book, Breasts: A Natural and Unnatural History,
Williams offers her take on — among other things — why breasts are getting bigger and
developing earlier, why tumors seem to gravitate toward the breast, and how toxins from the
environment may be affecting hormones and breast development.
She says many of those toxins, including the flame retardants found in her breast milk, may come
from ordinary household items like couches and electronics, which often contain flame retardants.
Some animal studies have shown that certain types of flame retardants interact with hormone...
Listen here
Tuesday, May 08, 2012
Study Claims Migraines More Likely for People With Celiac Disease
Wednesday, April 25, 2012
Study: MRI sheds light on cognitive risks for very preterm infants
White matter injury on term MRI of very preterm-born infants is predictive of future cognitive impairment, according to a study published in the May issue of Pediatrics. This discovery further supports the benefit of obtaining term MRI for very preterm-born infants, according to the authors.
“Because ultrasound scans are insensitive to most MRI findings, early MRI may help identify a group of very preterm born infants with an increased risk of later cognitive impairment,” wrote Osuke Iwata, MD, of the department of paediatrics and child health at Kurume University School of Medicine in Kurume, Japan, and colleagues. “Such information may provide an important key to improve follow-up strategies and to allow better risk stratification for future clinical trials which enroll very preterm born infants.”
While previous studies have demonstrated associations between white matter injury and cognitive impairment in very preterm-born children, this study is the first longitudinal study comparing term MRI findings, based on an MRI completed at term age, with outcomes at nine years old, according to the authors.
Seventy-six very preterm-born infants were imaged as part of the prospective study. Neurodevelopmental outcomes were assessed at 9 years old in 60 subjects using the Wechsler Intelligence Scale for Children, which tests different IQ indices.
Overall, mildly low intelligence scores (less than 85) were observed in 23.3 percent of the study cohort for verbal IQ, 41.7 percent for performance IQ and 30 percent for full-scale IQ. Moderately low scores (less than 70) were observed in 3.3 percent for verbal IQ and 11.7 percent for both performance IQ and full-scale IQ. Cerebral palsy was diagnosed in 10 percent of the children and 56.7 percent required special assistance at school.
Abnormal white matter appearances on the term MRI were predictive of mildly and moderately low performance and full-scale IQ scores, as well as cerebral palsy and the need for special assistance at school. It was also predictive of mildly low verbal IQs, but not moderately low verbal scores. Abnormal gray matter appearances did not predict any of the outcome measures.
“In very preterm born children, reduced cortical gray matter volume has also been associated with poor cognitive outcome at school age. In our current study, abnormal gray matter appearances at term were associated with the presence of white matter injury but not with any of the outcome measures at nine years old,” wrote Sachiko Iwata, MD, and colleagues. They explained that cortical gray matter lesions may contribute less to later cognitive functioning because neurologic functioning associated with gray matter injury may be affected more by other factors, such as education and family environment.
The authors concluded that term MRI may be able to help screen preterm-born infants and aid in earlier diagnosis of cognitive impairment.
“Additional studies with longer follow-up periods are still required, because neurodevelopmental assessments performed at early childhood period may not reflect cognitive functioning at school age and thereafter, either because of the limited reliability of early assessment tools or because cognitive function itself may significantly alter under the influence of numerous intrinsic/extrinsic factors such as plasticity, compensation, reorganization of injured brain, environment, and education.”
Friday, March 09, 2012
Maternal Obesity May Influence Brain Development of Premature Infants
Obesity is a modifiable risk factor that can affect cognition. JR
Maternal Obesity May Influence Brain Development of Premature Infants
Published in the March issue of the journal Pediatrics, the study looked at 921 infants born before 28 weeks of gestation during 2002 to 2004 at 14 participating institutions. The researchers assessed the babies' placenta for infection and other abnormalities, interviewed the mothers and reviewed their medical records. At age 2, the children's cognitive skills were evaluated using the Mental Development Index (MDI) portion of the Bayley Scales of Infant Development, a commonly used measure.
The scientists found that both maternal obesity and lack of high school education were associated with impaired early cognitive function, as was pre-term thrombosis (blood clot) in the placenta.
"We weren't really surprised by the socioeconomic factors because it has been repeatedly shown that social disadvantage predicts worse infant outcomes," Helderman said. "However, obesity is of particular interest because it is becoming more prevalent and it is potentially modifiable during the pre-conception period and pregnancy."
Obesity has been linked to inflammation, and inflammation can damage the developing brain, Helderman said. What isn't known is if the obesity-related inflammation in the mother is transmitted to the fetus.
"Few studies have addressed prenatal risk factors of cognitive impairment for infants born this prematurely. The long-term goal is to use information from studies like ours to develop treatments that prevent cognitive impairment in extremely premature babies," Helderman said.
Helderman's colleague, Michael O'Shea, M.D., section head of neonatology at Wake Forest Baptist, is currently conducting a study that follows these same babies into mid-childhood to determine long-term cognitive problems.
More than 30,000 extremely premature babies are born each year in the United States.